Carlyle Group to acquire 20% stake in India-based Piramal Pharma for $490m

This article was originally published here

Piramal Pharma comprises four businesses, which includes a contract development and manufacturing (CDMO) business called Piramal Pharma Solutions. The pharma group also runs a complex hospital generics business

The post Carlyle Group to acquire 20% stake in India-based Piramal Pharma for $490m appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply